P

Peter S. Linsley

Rosetta Stone (United States)

ORCID: 0000-0002-8960-4307

Publishes on T-cell and B-cell Immunology, Immune Cell Function and Interaction, Immunotherapy and Immune Responses. 351 papers and 73.6k citations.

PubIndex Score98Top 2%How it's scored

351Publications

73.6kTotal Citations

First publication: 1978First senior author: 1990

T-cell and B-cell Immunology Immune Cell Function and Interaction Immunotherapy and Immune Responses Diabetes and associated disorders MicroRNA in disease regulation

Top publicationsby citations

CTLA-4 is a second receptor for the B cell activation antigen B7.

Peter S. Linsley, J A Ledbetter|The Journal of Experimental Medicine|1991

Cited by 1.7k

Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing

Aimee L. Jackson, Peter S. Linsley|RNA|2006

Cited by 785

Rational Development of LEA29Y (belatacept), a High-Affinity Variant of CTLA4-Ig with Potent Immunosuppressive Properties

Christian P. Larsen, Robert Peach, Lori A. Turk et al.|American Journal of Transplantation|2005

Cited by 708

Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.

Robert Peach, Peter S. Linsley, Jürgen Bajorath et al.|The Journal of Experimental Medicine|1994

Cited by 246

Covalent Dimerization of CD28/CTLA-4 and Oligomerization of CD80/CD86 Regulate T Cell Costimulatory Interactions

JoAnne L. Greene, Peter S. Linsley, Gina Leytze et al.|Journal of Biological Chemistry|1996

Cited by 238